¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mass action transmission"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • interferential action
    °£¼·ÀÛ¿ë
  • monophasic action potential
    ´Ü»óȰµ¿ÀüÀ§
  • nerve action potential
    ½Å°æÈ°µ¿ÀüÀ§
  • neurotropic action
    Çâ½Å°æÀÛ¿ë
  • photochemical action
    ±¤È­ÇÐÀÛ¿ë
  • polyphasic action potential
    ´Ù»óȰµ¿ÀüÀ§
  • primary action
    ÀÏÂ÷ÀÛ¿ë
  • promotor action
    ÃËÁøÀÛ¿ë
  • pharmacological action
    ¾à¸®ÀÛ¿ë
  • reflex action
    ¹Ý»çÀÛ¿ë
  • reverse action clasp
    ¿ªÀÛ¿ë°¥°í¸®
  • specific action
    ƯÀÌÀÛ¿ë
  • synergistic action
    »ó½ÂÀÛ¿ë
  • sensory nerve action potential
    °¨°¢½Å°æÈ°µ¿ÀüÀ§
  • serrated action potential
    Åé´ÏȰµ¿ÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • diastatic action
    ´çÈ­ÀÛ¿ë
  • dual block action
    ÀÌÁßÂ÷´ÜÀÛ¿ë
  • dynamic action
    µ¿·ÂÀÛ¿ë
  • gestagenic action
    ÇÁ·Î°Ô½ºÅ×·ÐÀÛ¿ë, Ȳüȣ¸£¸óÀÛ¿ë
  • immediate action
    Áï°¢ÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • inotropic action
    ¼öÃàÃËÁøÀÛ¿ë
  • interferential action
    °£¼·ÀÛ¿ë
  • neurotropic action
    Çâ½Å°æÀÛ¿ë
  • pharmacological action
    ¾à¸®ÀÛ¿ë
  • photochemical action
    ±¤È­ÇÐÀÛ¿ë
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
  • promotor action
    ÃËÁøÀÛ¿ë
  • reflex action
    ¹Ý»çÀÛ¿ë
  • specific action
    ƯÀÌÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • inotropic action
    º¯·ÂÀÛ¿ë(ܨÕôíÂéÄ), ¼öÃàÃËÁøÀÛ¿ë(â¥õêõµòäíÂéÄ).³»°ú¼öÃà·Â
  • inotropic action
    º¯·ÂÀÛ¿ë, ¼öÃàÃËÁøÀÛ¿ë.[³»°ú]¼öÃà·Â º¯µ¿ÀÛ¿ë.
  • pharmacodynamic action
    ¾à¿ªÇÐ(Àû) ÀÛ¿ë(å·æ³ùÊ(îÜ) íÂéÄ).
  • photochemical action
    ±¤È­ÇÐÀÛ¿ë(ÊÙËöËí).
  • photodynamic action
    ±¤¿ªÇÐÀÛ¿ë(ÎÃæ³ùÊ íÂéÄ).
  • physical action
    ¹°¸®Àû ÀÛ¿ë(¡­íÂéÄ).
  • physiological action
    »ý¸®ÀÛ¿ë(¡­íÂéÄ).
  • primary action
    ÀÏÂ÷±â´É
  • principle of least action
    ÃÖ¼ÒÀÛ¿ëÀÇ ¿ø¸®(õÌá´íÂéÄ¡­ê«ìµ).
  • prolonged action drug
    Áö¼Ó¼º ¾àÁ¦(ò¥áÙàõå·ð¥).
  • prolonged action drug
    Ưȿ¼º ¾àÁ¦(÷åüùàõå·ð¥), Áö¼Ó¼º ¾àÁ¦(ò¥áÙàõå·ð¥).
  • promotor action
    ÃËÁøÀÛ¿ë.
  • protoplasmic action
    ¿øÇüÁúÀÛ¿ë(¡­íÂéÄ).
  • reflex action
    ¹Ý»çÀÛ¿ë.
  • remote action
    ¿ø°ÝÀÛ¿ë(êÀ̰íÂéÄ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • body-mass index
    ½ÅüÁú·®Áö¼ö(ãóô÷òõÕáò¦â¦)
  • cardiac mass
    ½ÉÀåÁ¾·ù(ãýíôðþ×»),Á¾±«(ðþÎÔ)
  • cavitated mass
    °øµ¿¼º Á¾±«
  • cell mass
    ¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
  • cell mass
    ¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
  • charge-to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • cheesy mass
    °Ç¶ô¼º Á¾±«
  • congenital neck mass
    ¼±Ãµ(¼º) °æºÎÁ¾±«
  • dorsal mass
    µîÂʵ¢ÀÌ
  • echogenic mass
    ¿¡ÄÚ ¹ß»ý Á¾±«
  • effective mass
    À¯È¿Áú·®.
  • electronic mass
    ÀüÀÚÁú·®.
  • embryonic mass
    ¹èÀÚµ¢ÀÌ
  • equivalent mass
    µî°¡Áú·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
NMT neuromuscular tension; neuromuscular transmission; N-methyltransferase; N-myristoyltransferase; no m...
PTI pancreatic trypsin inhibitor; persistent tolerant infection; Pictorial Test of Intelligence; placent...
PTN pain transmission neuron; pleiotrophin; posterior tibial nerve
PTT partial thromboplastin time; particle transport time; posterior tibial tendon (transfer); prothrombi...
RPT rapid pull-through; refractory period of transmission; Registered Physical Therapist; renal parenchy...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
TRD Transmission ratio distortion
AP Action Potential
APA Action potential amplitude
APD Action potential duration
APD(50) Action potential duration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • polypoid mass
    Æú¸³¾ç Á¾±«
  • protruding lateral mass
    µ¹Ãâ Ãø¸é
  • sonolucent mass
    ÃÊÀ½ÆÄ Åõ°ú¼º Á¾±«
  • tissue mass
    Á¶Á÷ µ¢¾î¸®
  • tumor mass
    Á¾¾ç
  • virtual mass
    °¡»ó Áú·®
  • action mechanism
    ÀÛ¿ë ±âÀü
    ¾î¶² ±â´ÉÀÌ ÀϾ°Ô µÇ´Â °úÁ¤°ú °æ°ú.
  • action onset
    ÀÛ¿ë °³½Ã
  • action potential
    Ȱµ¿ ÀüÀ§, Ȱµ¿ Àü¾Ð
    ±ÙÀ°¼¼Æ÷ ¶Ç´Â ½Å°æ¼¼Æ÷°¡ ÈïºÐÇÒ ¶§ »ý±â´Â Àü±âÀû Ȱ¼ºÀ¸·Î¼­, Àü±âÀû, È­ÇÐÀû, ±â°èÀû ÀÚ±Ø ¹× ¿Âµµº¯È­ µî¿¡ ÀÇÇÏ¿© »ý±ä´Ù°í »ý°¢Çϰí ÀÖ´Ù.
  • action variable
    ÀÛ¿ë º¯¼ö
  • adverse action
    À¯ÇØÀÛ¿ë
  • analgetic action
    ÁøÅë ÀÛ¿ë
  • antagonistic action
    ±æÇ× ÀÛ¿ë
  • antidiuretic action
    Ç×ÀÌ´¢ÀÛ¿ë
  • antimicrobial action
    Ç×±Õ ÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
apperceptive mass The already existing knowledge base in a similar or related area with which the new perceptual material is articulated.
(05 Mar 2000)
atomic mass <chemistry, physics> The mass of an atom relative to other atoms.
The present-day basis of the scale of atomic weights is carbon, the most common isotope of this element has arbitrarily been assigned an atomic weight of 12.
The unit of the scale is 1/12 the weight of the carbon atom or roughly the mass of one proton or one neutron. The atomic weight of any element is approximately equal to the total number of protons and neutrons in is nucleus
(16 Dec 1997)
atomic mass unit <chemistry> One-twelfth the mass of a neutral atom of the most abundant isotope of carbon.
(16 Dec 1997)
bilateral adrenal mass <radiology> Acute granulomatous disease (e.g., TB), metastases (bilateral in 15%), pheochromocytoma (bilateral in 10%), adrenal hyperplasia (adenoma), spontaneous adrenal haemorrhage
(12 Dec 1998)
body mass index One of the anthropometric measures of body mass; it has the highest correlation with skinfold thickness or body density.
(12 Dec 1998)
breast mass <oncology, surgery> A breast lump may be benign or cancerous.
Examples of breast lumps include: breast abscess, fat necrosis, fibroadenoma, fibrocystic breast disease and breast cancer. A breast biopsy is the best way to determine the aetiology of a breast lump. Remember, 80 to 85% of all biopsies are benign.
(27 Sep 1997)
para-sellar mass <radiology> Mnemonic: SATCHMO, S sphenoid sinus tumour, A aneurysm / adenoma of pituitary, T teratoid lesion, C craniopharyngioma, H hypothalamic glioma / histiocytoma, M meningioma / metastasis, O optic glioma less common lesions: germinoma, epidermoid, hamartoma, chordoma, arachnoid cyst
(12 Dec 1998)
mass <chemistry> The quantity of matter in an object.
(09 Jan 1998)
mass at base of tongue <radiology> Lingual thyroid, thyroglossal duct cyst, haemangioma, other neoplasm
(12 Dec 1998)
mass attenuation coefficient <physics> The mass attenuation coefficient, u/p, of a material for uncharged ionising particles is the quotient of DN/N by pdl, where DN/N is the fraction of particles that experience interactions in traversing a distance dl in a material of density p.
(16 Dec 1997)
mass behaviour Collective behaviour of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.
(12 Dec 1998)
mass burn facility A facility in which the pretreatment of MSW includes only inspection and simple separation to remove oversize, hazardous, or explosive materials. Large mass burn facilities have capacities of 3000 tons of MSW per day or more. Modular plants with capacities as low as 25 tons per day have been built. Mass burn technologies represent over 75% of all the MSW-to-energy facilities constructed in the United States to date. The major components of a mass burn facility include refuse receiving and handling, combustion and steam generation, flue gas cleaning, power generation, condenser cooling water, residue hauling, and storage.
(05 Dec 1998)
mass chest X-ray X-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest.
(12 Dec 1998)
mass defect <chemistry, radiobiology> Of a nucleus, the difference between the sum of the masses of the constituent nucleons and the mass of the nucleus.
(16 Dec 1997)
mass effect <neurology> Damage to the brain due the bulk of a tumour, the blockage of fluid or excess accumulation of fluid within the skull.
(16 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mass game
    Áý´Ü °æ±â
  • mass grave
    °øµ¿ ¹¦Áö (µ¿½Ã¿¡ ¸ÅÀåµÈ ¸¹Àº »ç¶÷µéÀÇ ¹¦Áö)
  • mass leave
    (Àεµ¿¡¼­ Ç×ÀÇÇϱâ À§ÇØ ¸¹Àº Á¾¾÷¿øÀÌ ÇÏ´Â) ÀÏÁ¦ ÈÞ°¡
  • mass man
    ´ëÁßÀû(Áý´Ü) Àΰ£ (´ëÁß »çȸ¸¦ ±¸¼ºÇÏ´Â °¡Á¤µÈ ÀüÇüÀû Àΰ£À¸·Î,°³¼ºÀÌ »ó½ÇµÊ)
  • mass media
    ´ëÁß Àü´Þ ±â°ü (¹æ¼Û,½Å¹®µî) (sing,mass medium)
  • mass medication
    (»ó¼öµµ¿¡ ¾à¹°À» ³Ö´Â ½ÄÀÇ) Áý´Ü Åõ¾à
  • mass meeting
    (ƯÈ÷ Á¤Ä¡Àû) ´ëÁß Áýȸ
  • mass metting
    (±¹¹Î) ´ëȸ
  • mass movement
    Áý´Ü À̵¿;´ëÁß ¿îµ¿
  • mass noun
    Áú·® ¸í»ç (uncountable ·Î¼­ ¹°Áú ¸í»ç¿Í Ãß»ó ¸í»ç¸¦ Æ÷ÇÔ)
  • mass number
    Áú·®¼ö(¿øÀÚÇÙ³»ÀÇ ¾çÀÚ¿Í Áß¼ºÀÚ¿ÍÀÇ ÃѼö,±âÈ£ A)
  • mass obervation
    ¿©·Ð Á¶»ç
  • mass priest
    ¹Ì»ç ¸Ã¾Æº¸´Â »çÁ¦;(°æ¸ê) Ä«Å縯 »çÁ¦
  • mass production
    ´ë·® »ý»ê 6
  • mass psychology
    ±ºÁß ½É¸®ÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á